About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Scientists develop gel from spider silk proteins for biomedical applications

Short Wave Pharma to start clinical trial for anorexia nervosa treatment

Roche announces influenza drug approval and new COVID test

Aptinyx fibromyalgia drug misses endpoint

argenx secures European Commission approval for generalized myasthenia gravis treatment

Beyond Biotech podcast 9: ARCH Venture Partners, Micropep, PTC Therapeutics, Valneva

ADVERTISEMENT

Regen BioPharma develops new approach for boosting CAR-T cell efficiency to treat solid tumors

Synlogic gets Ginkgo Bioworks’ help to launch T. rex inspired synthetic biotic for gout

Aro Biotherapeutics gets FDA orphan drug designation for treatment of Pompe Disease

GentiBio and Bristol Myers Squibb to develop engineered Treg therapies for inflammatory bowel diseases

Research discovery may help diagnose and treat cancer and brain disorders

Epilepsy drug accepted for review in Canada and Israel

ADVERTISEMENT